Metabotropic glutamate receptors as a target for anticonvulsant and anxiolytic action in immature rats

Epilepsia

Volumn 51, Issue SUPPL. 3, 2010, Pages 24-26

  Mareš, Pavel ^a   Mikulecká, Anna ^a   Tichá, Kateřina ^a   Lojková Janečková, Denisa ^a   Kubová, Hana ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Anticonvulsant action; Anxiolytic action; Metabotropic glutamate receptors; Motor performance; Rat ontogeny

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 3 [(2 METHYL 4 THIAZOLYL)ETHYNYL]PYRIDINE; METABOTROPIC RECEPTOR; PENTETRAZOLE;

ANTICONVULSANT ACTIVITY; CONFERENCE PAPER; ELECTROSTIMULATION; GENERALIZED EPILEPSY; NONHUMAN; PRIORITY JOURNAL; TONIC CLONIC SEIZURE; TRANQUILIZING ACTIVITY;

AGE FACTORS; ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ELECTRIC STIMULATION; EPILEPSY; INDANS; PSYCHOMOTOR PERFORMANCE; PYRIDINES; RATS; RECEPTORS, METABOTROPIC GLUTAMATE; THIAZOLES;

EID: 77954508600     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02604.x     Document Type: Conference Paper

References (20)

1. Alexander GM, Godwin DW. (2006) Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy. Epilepsy Res 71: 1-22.
2. Borowicz K, Luszczki JJ, Czuczwar SJ. (2009) 2-Methyl-6-phenylethynyl- pyridine (MPEP), a non-competitive mGluR5 antagonist, differentially affects the anticonvulsant activity of four conventional antiepileptic drugs against amygdala-kindled seizures in rats. Pharmacol Rep 61:621-630.
3. Cartmell J, Schoepp DD. (2000) Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 75:889-907. (Pubitemid 30660476)
4. Greenwood RS, Fan Z, McHugh R, Meeker R. (2000) Inhibition of hippocampal kindling by metabotropic glutamate receptor antisense oligonucleotides. Mol Cell Neurosci 16:233-243.
5. Hauser WA. (1995) Epidemiology of epilepsy in children. Neurosurg Clin N Am 6:419-429.
6. Kubová H, Mareš P. (1991) Anticonvulsant effects of phenobarbital and primidone during ontogenesis in rats. Epilepsy Res 10:148-155.
7. Lojková D, Mareš P. (2005) Anticonvulsant action of an antagonist of metabotropic glutamate receptors mGluR5 MPEP in immature rats. Neuropharmacology 49:219-229.
8. Lojková-Janečková D, Ng J, Mareš P. (2009) Antagonists of group I metabotropic glutamate receptors and cortical afterdischarges in immature rats. Epilepsia 50:2123-2129.
9. Loscher W, Dekundy A, Nagel J, Danysz W, Parsons CG, Potschka H. (2006) mGlu1 and mGlu5 receptor antagonists lack anticonvulsant efficacy in rodent models of difficult-to-treat partial epilepsy. Neuropharmacology 50:1006-1015.
10. Mareš P, Mikulecká A. (2004) MPEP, an antagonist of metabotropic glutamate receptors, exhibits anticonvulsant action in immature rats without a serious impairment of motor performance. Epilepsy Res 60:17-26.
11. Mareš P. (2009) Age-dependent anticonvulsant action of antagonists of group I glutamate metabotropic receptors in rats. Epilepsy Res 83: 215-223.
12. Meldrum BS, Chapman AG. (1999) Excitatory amino acid receptors and antiepileptic drug development. Adv Neurol 79:965-978.
13. Merliln LR. (2002) Differential roles for mGluR1 and mGluR5 in the persistent prolongation of epileptiform bursts. J Neurophysiol 87:621-625.
14. Mikulecká A, Mareš P. (2009) Effects of mGluR5 and mGluR1 antagonists on anxiety-like behavior and learning in developing rats. Behav Brain Res 204:133-139.
15. Moldrich RX, Chapman AG, De Sarro G, Meldrum BS. (2003) Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Eur J Pharmacol 576:3-16.
16. Palucha A, Pilc A. (2007) Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacol Ther 115:116-147. (Pubitemid 46992810)
17. Stanková L, Kožuchová A, Mareš P. (1997) Anticonvulsant effect of progabide in rats during ontogenesis. Physiol Res 46:47-52. (Pubitemid 27167988)
18. Tang FR, Bradford HF, Ling EA. (2009) Metabotropic glutamate receptors in the control of neuronal activity and as targets for development of anti-epileptogenic drugs. Curr Med Chem 16:2189-2204.
19. Thuault SJ, Davies CH, Randall AD, Collingridge GL. (2002) Group I mGluRs modulate the pattern of non-synaptic epileptiform activity in the hippocampus. Neuropharmacology 43:141-146.
20. Velíšek L, Kubová H, Pohl M, Staňková L, Mareš P, Schickerová R. (1992) Pentylenetetrazol-induced seizures in rats: an ontogenetic study. Naunyn-Schmiedeberg's Arch Pharmacol 346:588-591.